This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Precision Engineering of the Genome, Epigenome and Transcriptome - VIRTUAL CONTENT AVAILABLE ON DEMAND
joint with Plant Genome Engineering: From Lab to Field - VIRTUAL CONTENT AVAILABLE ON DEMAND
Organizer(s): Charles Gersbach, Rachel E. Haurwitz and Fyodor D. Urnov
Date: March 08 - 10, 2021
Location: Virtual at your computer. Recorded presentation content is available On Demand.
Sponsored by Novo Nordisk A/S, Synthego, TCR² Therapeutics and Vertex Pharmaceuticals Incorporated.
For important information on the coronavirus, please click here
Summary of Meeting:
Over the last several years, new genome engineering tools have revolutionized the ability to interrogate biological systems, engineer innovative biotechnologies, and model and treat human disease. The genome engineering field continues to evolve at a frenzied pace, including both the development of new fundamental tools and their application to addressing societal needs. This Keystone Symposia conference will cover this spectrum of advances, including the most recent technological innovations in genome, epigenome, and transcriptome precision engineering. The conference will also highlight recent advances in developing human therapeutics with these tools, including emerging clinical trial results and preclinical examples of novel modes of intervention. The conference will include a variety of topics of interest to the broad research community, including next-generation applications such as high-throughput screening, synthetic biology, and chromatin and RNA imaging and diagnostics. Finally, the conference will conclude with examples of how emerging technologies can be integrated for an unprecedented level of resolution of cellular processes, such as genome engineering combined with single-cell analysis methods. Collectively, this meeting will build on its history of success by familiarizing the audience with the latest advances in tool development, providing an update on clinical application of these tools, and generating an appreciation for the breadth of scientific areas impacted by the Genome Engineering Revolution.
Scholarship Deadline: February 22 2021
Abstract Deadline: February 9 2021
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
BlueRock TherapeuticsNovo Nordisk A/SSynthegoTCR² TherapeuticsVertex Pharmaceuticals Incorporated
We gratefully acknowledge additional support from these exhibitors at this conference:
Intellia Therapeutics
We gratefully acknowledge additional support for this conference from:
DCVC BioHorizon DiscoveryResolve BioSciences GmbH
We gratefully acknowledge the generous grant for this conference provided by:

National Center for Advancing Translational Sciences (NCATS)
Grant No. 1R13TR003731-01
Funding for this conference was made possible (in part) by 1R13TR003731-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found